Ludovic Lacroix
Impact in
- Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Oncology top 0.5%
- Cancer Cells and Metastasis
- Lung Cancer Research Studies
- Cancer Immunotherapy and Biomarkers
Papers in
-
- Cancer Genomics and Diagnostics 57
-
- Lung Cancer Treatments and Mutations 63
- Co-authors
- Martin Jean Schlumberger (21 shared papers)Fabrice André (31 shared papers)Bernard Caillou (25 shared papers)Jean‐Charles Soria (38 shared papers)Sébastiano Filetti (13 shared papers)David Planchard (29 shared papers)Monique Talbot (14 shared papers)Jean-Michel Bidart (8 shared papers)
- Journals
- Annals of Oncology (31 papers)European Journal of Cancer (17 papers)Clinical Cancer Research (17 papers)Journal of Thoracic Oncology (10 papers)The Journal of Clinical Endocrinology & Metabolism (9 papers)
- Partner nations
- FranceItalyUnited States
In The Last Decade
Ludovic Lacroix
243 papers receiving 13.4k citations
Ludovic Lacroix's Hit Papers
Peers
Comparison fields: 5 of 152
- Cancer Research 3.5k
- Oncology 4.3k
- Genetics 1.2k
- Endocrinology, Diabetes and Metabolism 1.8k
- Pulmonary and Respiratory Medicine 3.5k
Countries citing papers authored by Ludovic Lacroix
This map shows the geographic impact of Ludovic Lacroix's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ludovic Lacroix with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ludovic Lacroix more than expected).
Fields of papers citing papers by Ludovic Lacroix
This network shows the impact of papers produced by Ludovic Lacroix. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ludovic Lacroix. The network helps show where Ludovic Lacroix may publish in the future.
Co-authors
The 25 scholars most cited alongside Ludovic Lacroix, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 250 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC Hit paper breakdown → | 2015 | 681 |
| 2 | High-Throughput Genomics and Clinical Outcome in Hard-to-Treat Advanced Cancers: Results of the MOSCATO 01 Trial Hit paper breakdown → | 2017 | 597 |
| 3 | Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes Hit paper breakdown → | 2015 | 502 |
| 4 | Systemic short chain fatty acids limit antitumor effect of CTLA-4 blockade in hosts with cancer Hit paper breakdown → | 2020 | 424 |
| 5 | 2011 | 374 | |
| 6 | 2011 | 347 | |
| 7 | 2014 | 320 | |
| 8 | Polyclonal RB1 mutations and acquired resistance to CDK 4/6 inhibitors in patients with metastatic breast cancer Hit paper breakdown → | 2017 | 316 |
| 9 | Mutational Profile of Metastatic Breast Cancers: A Retrospective Analysis Hit paper breakdown → | 2016 | 314 |
| 10 | 2012 | 309 | |
| 11 | Trastuzumab deruxtecan in metastatic breast cancer with variable HER2 expression: the phase 2 DAISY trial Hit paper breakdown → | 2023 | 294 |
| 12 | 2015 | 277 | |
| 13 | 1999 | 274 | |
| 14 | 2013 | 266 | |
| 15 | 2020 | 233 | |
| 16 | 2013 | 167 | |
| 17 | 2017 | 160 | |
| 18 | 2017 | 151 | |
| 19 | 2022 | 141 | |
| 20 | 2019 | 136 |
About Ludovic Lacroix
Ludovic Lacroix is a scholar working on Cancer Research, Pulmonary and Respiratory Medicine, Oncology, Endocrinology, Diabetes and Metabolism and Pathology and Forensic Medicine, having authored 250 papers that have together received 13.7k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (63 papers), Cancer Genomics and Diagnostics (57 papers), Thyroid Cancer Diagnosis and Treatment (26 papers), Genetic factors in colorectal cancer (15 papers), Thyroid Disorders and Treatments (13 papers), RNA modifications and cancer (11 papers), Colorectal Cancer Treatments and Studies (10 papers) and Glioma Diagnosis and Treatment (9 papers). The work is most often cited by research in Cancer Research (3.5k citations), Oncology (4.3k citations), Genetics (1.2k citations), Endocrinology, Diabetes and Metabolism (1.8k citations) and Pulmonary and Respiratory Medicine (3.5k citations). Ludovic Lacroix has collaborated with scholars based in France, Italy and United States. Frequent co-authors include Martin Jean Schlumberger, Fabrice André, Bernard Caillou, Jean‐Charles Soria, Sébastiano Filetti, David Planchard, Monique Talbot, Jean-Michel Bidart, Vladimir Lazar and Abir Al Ghuzlan. Their work appears in journals such as Annals of Oncology, European Journal of Cancer, Clinical Cancer Research, Journal of Thoracic Oncology and The Journal of Clinical Endocrinology & Metabolism.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.